INHIBITORS OF ENDOGENOUS NITROGEN-OXIDE FORMATION BLOCK THE PROMOTION OF NEOPLASTIC TRANSFORMATION IN C3H 10T1/2 FIBROBLASTS

被引:90
作者
MORDAN, LJ
BURNETT, TS
ZHANG, LX
TOM, J
COONEY, RV
机构
[1] Molecular Oncology Program, Cancer Research Center of Hawaii, University of Hawaii at Manoa, Honolulu, HI 96813
关键词
D O I
10.1093/carcin/14.8.1555
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The endogenous production of nitric oxide (NO) and its role in the neoplastic transformation of C3H 10T1/2 mouse fibroblasts were investigated. NO production, as indicated by NO2- in the culture medium, was increased in cells initiated with 3-methylcholanthrene or stimulated with the combination of interferon-gamma (IFN-gamma ng/ml) plus bacterial lipopolysaccharide (LPS, 1 mug/ml). NO2 was detectable within 24-48 h of IFNgamma/LPS treatment and accumulated to micromolar concentrations within 4 days. NO production was inhibited in a dose-dependent manner by analogs of L-arginine in which the terminal guanidino nitrogen is blocked, consistent with NO production by the oxidative deamination of L-arginine by nitric oxide synthase (NOS). IFNgamma/LPS-stimulated cells expressed a 4.4 kb mRNA which hybridized to a probe for the mouse macrophage-inducible NOS. Expression of the rat cerebellar constitutive NOS was not detected in these cells. Arginine analogs added to the culture medium during the post-confluence promotional stages of the C3H 10T1/2 transformation assay blocked the formation of transformed foci in a dose-dependent manner comparable to their inhibition of NO production. These data demonstrate that C3H 10T1/2 mouse fibroblasts are a useful model for the study of the effects of endogenous NO production in carcinogenesis and suggest that NO plays a significant role in the promotional phase of neoplastic transformation of these cells.
引用
收藏
页码:1555 / 1559
页数:5
相关论文
共 40 条
[1]  
AMES BN, 1992, CURR COMMUN CELL MOL, V5, P1
[2]   MUTAGENICITY OF NITRIC-OXIDE AND ITS INHIBITION BY ANTIOXIDANTS [J].
ARROYO, PL ;
HATCHPIGOTT, V ;
MOWER, HF ;
COONEY, RV .
MUTATION RESEARCH, 1992, 281 (03) :193-202
[3]   A ROLE FOR NITRIC-OXIDE IN LONG-TERM POTENTIATION [J].
BON, C ;
BOHME, GA ;
DOBLE, A ;
STUTZMANN, JM ;
BLANCHARD, JC .
EUROPEAN JOURNAL OF NEUROSCIENCE, 1992, 4 (05) :420-424
[4]   CLONED AND EXPRESSED NITRIC-OXIDE SYNTHASE STRUCTURALLY RESEMBLES CYTOCHROME-P-450 REDUCTASE [J].
BREDT, DS ;
HWANG, PM ;
GLATT, CE ;
LOWENSTEIN, C ;
REED, RR ;
SNYDER, SH .
NATURE, 1991, 351 (6329) :714-718
[5]   INHIBITION OF RADIATION-INDUCED TRANSFORMATION INVITRO BY BACTERIAL-ENDOTOXINS [J].
CAREW, JA ;
COLLINS, MF ;
KENNEDY, AR .
CARCINOGENESIS, 1988, 9 (05) :725-729
[6]   GAMMA-TOCOPHEROL DETOXIFICATION OF NITROGEN-DIOXIDE - SUPERIORITY TO ALPHA-TOCOPHEROL [J].
COONEY, RV ;
FRANKE, AA ;
HARWOOD, PJ ;
HATCHPIGOTT, V ;
CUSTER, LJ ;
MORDAN, LJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (05) :1771-1775
[7]   CARCINOGENIC N-NITROSAMINE FORMATION - A REQUIREMENT FOR NITRIC-OXIDE [J].
COONEY, RV ;
HATCHPIGOTT, V ;
ROSS, PD ;
RAMSEYER, J .
JOURNAL OF ENVIRONMENTAL SCIENCE AND HEALTH PART A-ENVIRONMENTAL SCIENCE AND ENGINEERING & TOXIC AND HAZARDOUS SUBSTANCE CONTROL, 1992, A27 (03) :789-801
[8]   AMINOGUANIDINE, A NOVEL INHIBITOR OF NITRIC-OXIDE FORMATION, PREVENTS DIABETIC VASCULAR DYSFUNCTION [J].
CORBETT, JA ;
TILTON, RG ;
CHANG, K ;
HASAN, KS ;
IDO, Y ;
WANG, JL ;
SWEETLAND, MA ;
LANCASTER, JR ;
WILLIAMSON, JR ;
MCDANIEL, ML .
DIABETES, 1992, 41 (04) :552-556
[9]   SPONTANEOUS DEAMINATION OF CYTOSINE AND 5-METHYLCYTOSINE RESIDUES IN DNA AND REPLACEMENT OF 5-METHYLCYTOSINE RESIDUES WITH CYTOSINE RESIDUES [J].
EHRLICH, M ;
ZHANG, XY ;
INAMDAR, NM .
MUTATION RESEARCH, 1990, 238 (03) :277-286
[10]  
ELLISON BJ, 1992, CANCER RES, V52, P667